J&J wins FDA nod for Icotyde, a once-daily oral psoriasis pill, boosting its new drugs portfolio and challenging injectable treatments in a key market.
ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...
On February 10, 2026, the Saket Court issued a summons to Bina Modi and Lalit Bhasin in a case filed by her son Samir Modi. Delhi Police filed a charge sheet and said that there is no sufficient ...
Reps. Tom Gann, RInola, and Kevin West, RMoore, on Wednesday filed a brief asking the Oklahoma Supreme Court to overturn $98 million in rate increases for Oklahoma Natural Gas (ONG) well as $1.77 ...
Find all the best things to do in Pittsburgh this weekend, from NatureFest to the Pittsburgh Fringe Festival to the Japanese Film Festival.
Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...
Johnson & Johnson (JNJ) on Wednesday announced that the U.S. Food and Drug Administration (FDA) approved Icotyde, a once-daily pill developed with Protagonist Therapeutics (PTGX), as a treatment for ...
Pediatric patients with moderate to severe hidradenitits suppurativa may now receive secukinumab following new FDA approval for those aged 12 and up.
The season will feature shows with Jeff Goldblum and the Mildred Snitzer Orchestra and Hamilton’s Leslie Odom Jr.
US FDA approves Novartis Cosentyx for paediatric patients aged 12+ with moderate to severe hidradenitis suppurativa: Basel Monday, March 16, 2026, 14:00 Hrs [IST] Novartis announc ...
As war in the Middle East convulses global oil markets, Pakistan faces a stark choice between shielding consumers from fuel price shocks and meeting its commitments to the IMF.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results